About Vinflunine
            
            Class: | Antineoplastic agent, Vinca alkaloid derivative  
Use: | Treatment of advanced or metastatic transitional cell carcinoma of the bladder after prior chemotherapy  
Adult dose: | 320 mg/m² administered as an intravenous infusion over 20 minutes every 3 weeks  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Common side effects include constipation, fatigue, peripheral neuropathy, nausea, vomiting, and myelosuppression  
Contraindicat
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Vinca alkaloid derivative
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of advanced or metastatic transitional cell carcinoma of the bladder after prior chemotherapy
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Pierre Fabre Medicament Laboratories, FRANCE
                    
                    
                    Package Size
                    10ml Vial x 1
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5433.62
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        320 mg/m² administered as an intravenous infusion over 20 minutes every 3 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include constipation, fatigue, peripheral neuropathy, nausea, vomiting, and myelosuppression
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to vinflunine or any component of the formulation; severe bone marrow suppression; pregnancy and lactation
         
        
        
            
                Important Warnings
            
            Risk of severe neutropenia, infections, and bleeding; monitor blood counts regularly; may cause fetal harm; use caution in patients with hepatic impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.